News
Choosing the Right Financial Adviser
Are you in need of some financial assistance? If so, you may have considered seeking the help of a financial adviser. But what ...
News
The ‘Un-Recession’ of 2023: A Bold Prediction
As we enter the halfway point of the year, many experts are bracing themselves for a looming recession. But I’m here to make ...
News
MoonLake Immunotherapeutics Shares Double After Positive Trial Results
MoonLake Immunotherapeutics saw its shares double to $55 in premarket trading following positive trial results. The global Phase 2 trial evaluated the safety ...
News
Canadian Wholesale Sales Rebound in May
According to Statistics Canada, the advance estimate of Canadian wholesale sales rebounded in May 2020. The increase of 3.5% for the month, excluding ...
News
Brace for Impact: Hurricane Season 2023
As the 2023 hurricane season commences, it’s time to consider the financial implications of extreme weather conditions, and the industries that may suffer ...
News
GM’s Supply Agreement for Manganese Sulfate for EV Production
General Motors Co. (GM) has announced a new supply agreement with Element 25 Ltd. (E25), an Australia-based company, for a yearly supply of ...
News
Fintech Struggles to Deliver on Promise of Affordable Loans
For years, the financial technology industry has promised to identify good credit risks that big banks and traditional lenders might miss, providing people ...
News
Max July 2023 Releases
Max’s July 2023 schedule is filled with exciting releases, from dramas to documentaries. Here are some titles that we think you’ll enjoy. “Full ...
News
FibroGen Shares Plummet After Trial Misses Endpoint
By Chris Wack FibroGen’s shares have dropped significantly after the company reported that its recent trial for pamrevlumab has failed to meet its ...